# A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet

> **NCT03456960** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 276 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TAK-438ASA
- **DRUG:** TAK-438
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT03456960
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-08
- **Primary completion:** 2018-10-10
- **Final completion:** 2018-10-12
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2019-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03456960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03456960, "A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03456960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*